Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. ard.bmj.com › content › 76/1/292016 updated EULAR evidence-based recommendations for the...

   ard.bmj.com › content › 76/1/29

   • Αποθηκευμένο αντίγραφο

   1 Ιαν 2005 · Recommended first-line options for acute flare are colchicine (within 12 hours of flare onset) at a loading dose of 1 mg followed 1 hour later by 0.5 mg on day 1 and/or an NSAID (plus a proton pump inhibitor if appropriate), oral corticosteroids (30–35 mg/day of equivalent prednisolone for 3–5 days) or articular aspiration and injection of ...

2. www.nejm.org › doi › fullGout | New England Journal of Medicine

   www.nejm.org › doi › full

   16 Νοε 2022 · Gout manifests as painful, debilitating arthritis. Treatments are effective but often not prescribed properly. Management involves treatment for flares and ongoing medication to lower urate...

3. www.uptodate.com › contents › treatment-of-gout-flaresTreatment of gout flares - UpToDate

   www.uptodate.com › contents › treatment-of-gout-flares

   • Αποθηκευμένο αντίγραφο

   30 Νοε 2023 · Where 0.5 mg is the only available form, an initial dose of 1 mg may be used, followed by 0.5 mg one hour later for a total of 1.5 mg for the first day of therapy. Subsequently, the colchicine dose may be reduced to 0.5 mg twice daily until 48 hours after the resolution of the flare.

4. www.nature.com › articles › nrrheumOptimizing current treatment of gout | Nature Reviews...

   www.nature.com › articles › nrrheum

   11 Μαρ 2014 · To reduce the risk of ULT-induced flares, the EULAR guidelines recommend co-prescription of either low-dose colchicine (usually 0.5 mg once or twice daily) or an oral NSAID (plus PPI) as ...

5. www.amjmed.com › article › S0002-9343(21)00510-6Consensus Statement Regarding the Efficacy and Safety of...

   www.amjmed.com › article › S0002-9343(21)00510-6

   17 Αυγ 2021 · Over the last decade, evidence has demonstrated that long-term, low-dose colchicine (0.5 mg daily) is effective for preventing gout flare and cardiovascular (CV) events in a wide range of patients.

6. pubmed.ncbi.nlm.nih.gov › 34416165Consensus Statement Regarding the Efficacy and Safety of Long ......

   pubmed.ncbi.nlm.nih.gov › 34416165

   Over the last decade, evidence has demonstrated that long-term, low-dose colchicine (0.5 mg daily) is effective for preventing gout flare and cardiovascular (CV) events in a wide range of patients.

7. www.sciencedirect.com › science › articleAn updated systematic review and meta-analysis of randomised...

   www.sciencedirect.com › science › article

   1 Απρ 2024 · An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare. Author links open overlay panel. Vicky Tai a. , Peter Gow b. , Sarah Stewart a c. , Panchalee Satpanich d. , Changgui Li e f. , Abhishek Abhishek g. , Nicola Dalbeth a. Show more. Add to Mendeley.